KURA FY 2025 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$815M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+25.2% YoY

Gross Profit

$67M99.9% margin

Operating Income

-$304M-449.9% margin

Net Income

-$279M-412.9% margin

EPS (Diluted)

$-3.18

Cash Flow

Operating Cash Flow

-$64M

Free Cash Flow

-$71M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$738M

Total Liabilities

$564M

Stockholders' Equity

$174M

Cash & Equivalents

$149M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$54M	+25.2%
Gross Profit	$67M	$54M	+25.1%
Operating Income	-$304M	-$193M	-57.2%
Net Income	-$279M	-$174M	-60.2%